AXA/2025/FY/Earnings presentation: Difference between revisions
Content deleted Content added
doc_archive: publish snjra2xp9r (.md link) |
doc_archive: publish snjra2xp9r |
||
Line 10:
| pages = 49
| source_url = https://www-axa-com.cdn.prismic.io/www-axa-com/abwhxx5fn6DF3AUJ_AXA_Full_Year_Results_2025b.pdf
| summary_md =
| intro_sentence = This article summarizes AXA's Earnings presentation published on 2026-02-26 (49 pages).
| wide = yes
Line 19:
''This article summarizes AXA's Earnings presentation published on 2026-02-26 (49 pages).''
=== Full Year 2025 Earnings Presentation
=== Important legal information and cautionary statements concerning forward-looking statements and the use of non-gaap financial measures ===
{{chunk|doc=snjra2xp9r|c=1|p=2}}
======
* Certain statements in
* Forward-looking statements are identified by words like "expects", "anticipates", "may", "plan," "target", or conditional verbs such as "would" and "could".
* Statements regarding expected [[Definition:Underlying earnings per share|underlying earnings per share]] (UEPS) growth for [[Definition:Year 2026|2026]] are forward-looking and provide one-off guidance for the last year of the Group's current strategic plan.
* These statements are based on Management's current views and intentions and are subject to change.
* Undue reliance should not be placed on forward-looking statements due to known and unknown risks and uncertainties, many outside AXA's control, which can cause actual results to differ materially.
* Each forward-looking statement is valid only at the date of the presentation.
* Refer to Part 5 - "Risk Factors and Risk Management" of AXA's Universal Registration Document for the year ended December 31, 2024 (the "2024 Universal Registration Document") for a description of important factors, risks, and uncertainties affecting AXA's business and/or results of operations.
* AXA disclaims any obligation to publicly update or revise forward-looking statements, except as required by applicable laws and regulations.
* The presentation refers to non-GAAP financial measures, or alternative performance measures (APMs), used by Management to analyze operating trends, financial performance, and financial position.
* These non-GAAP measures may not be comparable to similarly labeled measures used by other companies and should not be considered in isolation from, or as a substitute for, the Group's consolidated financial statements prepared in accordance with IFRS.
* "[[Definition:Underlying earnings|Underlying earnings]]", UEPS ("underlying earnings per share"), "underlying return on equity", "combined ratio", and "debt gearing" are APMs as defined in ESMA's guidelines and the AMF's related position statement issued in 2015.
* AXA provides a reconciliation of APMs to the most closely related line item, subtotal, or total in the financial statements (and/or their calculation methodology) in its Activity Report as of December 31, 2025 ("AXA's 2025 Activity Report") under the heading "USE OF NON-GAAP AND ALTERNATIVE PERFORMANCE MEASURES".
* Further information on non-GAAP financial measures is available in the Glossary in AXA's 2025 Activity Report.
* AXA's Activity Report as of December 31, 2025 is available on the AXA Group website (www.axa.com).
* AXA's consolidated financial statements for the year ended December 31, 2025 were examined by the Board of Directors on February 25, 2026.
* The consolidated financial statements are subject to completion of an audit procedure by AXA's statutory auditors.
===
{{chunk|doc=snjra2xp9r|c=2|p=3}}
======
* The [[Definition:Full year 2025|FY25]] Highlights are on
* The FY25 Business Performance is on page 09 and presented by Guillaume Borie, Global Head of Finance, Strategy, Underwriting, Risk, and Technology.
* The FY25
== FY25 Highlights ==
{{chunk|doc=snjra2xp9r|c=3|p=4}}
====== Group CEO statement ======
* Thomas Buberl is the Group CEO.
Line 60 ⟶ 62:
{{chunk|doc=snjra2xp9r|c=4|p=5}}
======
* Revenues: +6% vs. [[Definition:Full year 2024|FY24]]
Line 66 ⟶ 68:
* ROE: 16% in [[Definition:Full year 2025|FY25]]
* Solvency II ratio: 224% in FY25
* DPS growth: +8%
* Annual [[Definition:Share buyback|share buyback]]: EUR 1.25bn
* Confident to deliver
{{chunk|doc=snjra2xp9r|c=
====== Full Year 2025 – Excellent performance ======
{{fn note|1=1|2=Based on the dividend proposed by
{{fn note|1=2|2=Following
=== Executing the plan on growth, margin and efficiency ===
{{chunk|doc=snjra2xp9r|c=
======
<div style="overflow-x:auto">
Line 91 ⟶ 89:
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" | Underlying earnings
| style="text-align:right" | 8.1
| style="text-align:right" | 8.4
|}
</div>
{{chunk|doc=snjra2xp9r|c=
======
* Group revenue +6% (+9% excluding [[Definition:AXA Investment Managers|AXA IM]])
* High organic growth: +6% top line growth, balanced across lines
** P&C: +5%
** Life: +9%
** Health: +5%
* Record profitability with further margin expansion in P&C and L&H
* Improvement in efficiency
* Scaling the business through continued investments in growth and technology
* Consistent earnings growth while enhancing reserve prudence
{{chunk|doc=snjra2xp9r|c=
====== Executing the plan on growth, margin and efficiency ======
Line 124 ⟶ 118:
==== Secular trends fueling demand across businesses ====
{{chunk|doc=snjra2xp9r|c=
======
* Protection gaps and emerging corporate risks
* Demographics
{{chunk|doc=snjra2xp9r|c=
======
<div style="overflow-x:auto">
Line 155 ⟶ 149:
|}
</div>
==== Our right to win ====
{{chunk|doc=snjra2xp9r|c=
======
* Leading brand and high customer NPS
* Strong and diversified distribution
* Technical expertise in pricing and underwriting risks
* Scale offering
=== Laying the foundation for the next plan ===
{{chunk|doc=snjra2xp9r|c=
====== Strategic priorities ======
Line 189 ⟶ 173:
== FY25 Business Performance ==
{{chunk|doc=snjra2xp9r|c=
======
* Guillaume Borie is
=== Strong delivery across our businesses ===
{{chunk|doc=snjra2xp9r|c=
====== Gross written premiums &
<div style="overflow-x:auto">
{| id="t3" class="wikitable"
|-
! style="text-align:left" | Segment
! style="text-align:right" | Gross written premiums
! style="text-align:right" | Underlying earnings
|-
| style="text-align:left" | France
| style="text-align:right" | +6%
| style="text-align:right" | +7%
|-
| style="text-align:left" | Europe
| style="text-align:right" | +6%
| style="text-align:right" | +9%
|-
| style="text-align:left" | AXA XL
| style="text-align:right" | +4%
| style="text-align:right" | +9%
|-
| style="text-align:left" | Asia, Africa & EME-LATAM
| style="text-align:right" | +13%
| style="text-align:right" | +6%
|}
</div>
Line 228 ⟶ 212:
=== P&C – Strong margins, confidence in sustaining growth ===
{{chunk|doc=snjra2xp9r|c=
====== P&C GWP and
* [[Definition:Gross written premiums|GWP]]
* 2025 / Beyond 2025 strategic focus:
** Retail and SME & Mid-market: Growing volumes while expanding margins (2025); Investing to improve customer retention and expanding distribution footprint (Beyond 2025).
** AXA XL (Large & Specialty): Profitable growth with stable margins (2025); Capitalizing on attractive growth opportunities and continued cycle management (Beyond 2025).
{{chunk|doc=snjra2xp9r|c=
======
* [[Definition:Underlying earnings|Underlying earnings]] +9% to EUR 5.9bn.
* Drivers include continued progress on efficiency, higher investment income, and the use of Data & AI to enhance customer experience and technical excellence.
{{chunk|doc=snjra2xp9r|c=
====== P&C – Strong margins, confidence in sustaining growth ======
Line 270 ⟶ 234:
=== L&H – Good momentum, well positioned to capture growth opportunities ===
{{chunk|doc=snjra2xp9r|c=
====== GWP
* [[Definition:Gross written premiums|GWP]]: EUR 57bn
{{chunk|doc=snjra2xp9r|c=
======
* Strategic focus areas for 2025 and beyond 2025 include:
** Long-term business:
*** Accelerating net flows in Savings with attractive margins
*** Capturing savings & retirement opportunities by sourcing the best asset management products for customers
** Short-term business:
*** Growing technical results while absorbing the Mexico VAT impact
*** Capitalizing on demand for health & protection while further improving margins
{{chunk|doc=snjra2xp9r|c=20|p=12}}
====== Underlying Earnings and Cost Reduction ======
* [[Definition:Underlying earnings|Underlying earnings]]: +7% to EUR 3.5bn ([[Definition:Full year 2025|FY25]] vs. [[Definition:Full year 2024|FY24]] at constant [[Definition:Foreign exchange|FX]])
* Focus on cost reduction
* Increasing penetration of Protection riders in Savings offerings
* Leveraging AI to reduce claims leakage and improve customer outcomes in Health
== FY25 Financial Performance ==
{{chunk|doc=snjra2xp9r|c=
====== Group CFO ======
Line 318 ⟶ 266:
=== P&C – Continued disciplined growth ===
==== GWP & Other Revenues ====
{{chunk|doc=snjra2xp9r|c=
====== GWP & other revenues by
<div style="overflow-x:auto">
{| id="
|-
! style="text-align:left" |
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
Line 369 ⟶ 312:
</div>
{{chunk|doc=snjra2xp9r|c=
====== Commercial
* Continued pricing momentum and volume growth in Mid-market and SME
* Growth in lines of business with attractive margins,
* Growth supported by alternative capital
* Favorable pricing trends and strong growth in net new contracts (+1.7m in [[Definition:Full year 2025|FY25]])
{{chunk|doc=snjra2xp9r|c=
====== GWP & Other Revenues ======
{{fn note|1=none|2=Change at constant scope and FX.}}
{{fn note|1=1|2=Price effect.}}
{{fn note|1=2|2=Includes exposure adjustments and mix & other effects.}}
Line 387 ⟶ 331:
==== Combined ratio ====
{{chunk|doc=snjra2xp9r|c=
====== Combined ratio ======
<div style="overflow-x:auto">
{| id="
|-
! style="text-align:left" |
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" | Undiscounted CY loss ratio (ex Nat Cat)
Line 420 ⟶ 360:
| style="text-align:right" | -3.6%
| style="text-align:right" | -3.5%
|-
| style="text-align:left" |
| style="text-align:right" | 91.0%
| style="text-align:right" | 90.6%
|}
</div>
{{chunk|doc=snjra2xp9r|c=
====== Combined ratio drivers ======
*
** Margin expansion in Commercial lines SME & mid-market business and Personal lines
** Stable AXA XL Insurance margins
**
** Nat Cat charges below normalized load
** Lower reliance on prior year reserve development
** Taking advantage of a good year to enhance reserve prudence
=== P&C – Earnings growth from higher underwriting and financial result ===
{{chunk|doc=snjra2xp9r|c=
====== P&C
* P&C earnings
{{chunk|doc=snjra2xp9r|c=
====== Underlying
<div style="overflow-x:auto">
{| id="
|-
! style="text-align:left" |
! class="col-s" style="text-align:right" |
|-
| style="text-align:left" | FY24
| style="text-align:right" | 5,510
|-
| style="text-align:left" | Volume growth
| style="text-align:right" | +292
|-
Line 464 ⟶ 403:
| style="text-align:right" | +189
|-
| style="text-align:left" | Investment income
| style="text-align:right" | +435
|-
| style="text-align:left" | Insurance finance expenses
| style="text-align:right" | -235
|-
Line 481 ⟶ 420:
</div>
{{chunk|doc=snjra2xp9r|c=
====== P&C earnings growth drivers ======
* P&C earnings grew +9% (at constant [[Definition:Foreign exchange|FX]]).
* Growth was driven by a better underwriting result from strong volume growth and an improved all-year combined ratio, while enhancing reserve prudence.
*
* Higher unwind of discount of claims reserves
* Unfavorable forex impact was notably due to USD depreciation vs. EUR.
* Underwriting result includes expenses.
{{chunk|doc=snjra2xp9r|c=
======
* [[Definition:Full year 2025|Full Year 2025]] Earnings.
=== Life & Health – Strong growth in premiums, positive net flows ===
{{chunk|doc=snjra2xp9r|c=
====== Life & Health premiums and net flows ======
* Life & Health premiums: EUR
**
** Group Protection & Health: EUR 6.0bn (+6% LFL)
** Savings: EUR 7.0bn (+6% LFL)
* Life & Health net flows: +EUR 0.2bn
** Individual Protection & Health: +EUR 1.0bn
** Group Protection & Health: +EUR 0.2bn
** Savings: -EUR 1.0bn
==== Life GWP & Other Revenues ====
{{chunk|doc=snjra2xp9r|c=32|p=17}}
====== Life GWP & Other Revenues ======
<div style="overflow-x:auto">
{| id="
|-
! style="text-align:left" |
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" |
|-
| style="text-align:left" | Total
Line 541 ⟶ 489:
</div>
==== Health GWP & Other Revenues ====
{{chunk|doc=snjra2xp9r|c=33|p=17}}
====== Health GWP & other revenues by segment ======
<div style="overflow-x:auto">
{| id="
|-
! style="text-align:left" |
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" |
|-
| style="text-align:left" | Total
Line 569 ⟶ 519:
</div>
==== Net flows: €+5.4bn ====
{{chunk|doc=snjra2xp9r|c=34|p=17}}
====== Net flows ======
* Net flows were EUR +1.5bn in [[Definition:Full year 2024|FY24]].
{{chunk|doc=snjra2xp9r|c=35|p=17}}
====== Net flows by business line ======
<div style="overflow-x:auto">
{| id="
|-
! style="text-align:left" |
! class="col-s" style="text-align:right" |
|-
| style="text-align:left" | Protection
Line 595 ⟶ 552:
</div>
{{chunk|doc=snjra2xp9r|c=
====== Employee Benefits
* Employee Benefits
* The change is at constant scope and [[Definition:Foreign exchange|FX]].
{{chunk|doc=snjra2xp9r|c=
====== Net flows: €+5.4bn ======
{{fn note|1=1|2=Including both short-term and long-term Employee Benefits GWP and other revenues.}}
Line 607 ⟶ 565:
=== Life & Health – Strong volume growth in Savings and Protection impacted by higher interest rates on discounting ===
{{chunk|doc=snjra2xp9r|c=
====== PVEP,
* PVEP was impacted by higher interest rates on discounting despite strong growth in Life volumes.
* NB CSM was driven by robust Savings & Protection sales, with reported growth impacted by higher interest rates for discounting of future profits.
* NBV was broadly stable as strong growth in NB CSM balanced lower contribution from short-term multinational business in France.
{{chunk|doc=snjra2xp9r|c=
====== Reporting basis ======
Line 703 ⟶ 579:
=== Life & Health – Growth in new business driving Normalized CSM growth ===
{{chunk|doc=snjra2xp9r|c=
======
<div style="overflow-x:auto">
{| id="
|-
! style="text-align:left" |
! class="col-s" style="text-align:right" |
! class="col-s" style="text-align:
! class="col-s" style="text-align:right" |
|-
| style="text-align:left" |
| style="text-align:right" | 33.6
| style="text-align:right" | 25.8
| style="text-align:right" | 7.7
|-
| style="text-align:left" | New business CSM
| style="text-align:right" | +2.2
| style="text-align:
| style="text-align:right" |
|-
| style="text-align:left" | Underlying return on in-force
| style="text-align:right" | +1.3
| style="text-align:right" |
| style="text-align:right" |
|-
| style="text-align:left" | CSM release
| style="text-align:right" | -3.0
| style="text-align:right" |
| style="text-align:right" |
|-
| style="text-align:left" | Economic variance
| style="text-align:right" | +0.6
| style="text-align:right" |
| style="text-align:right" |
|-
| style="text-align:left" | Operating variance
| style="text-align:right" | -0.3
| style="text-align:right" |
| style="text-align:right" |
|-
| style="text-align:left" | Affiliates, FX & other
| style="text-align:right" | -1.4
| style="text-align:right" |
| style="text-align:right" |
|-
|
| style="text-align:right" | 33.0
| style="text-align:right" | 25.4
| style="text-align:right" | 7.6
|}
</div>
{{chunk|doc=snjra2xp9r|c=
======
* Normalized CSM increased by +2%.
* CSM release growth reflected better margins and new business CSM growth, impacted by higher rates.
* Economic variance reflected government spreads tightening and positive equity market returns.
* Operating variance was driven by better margins and net flows, which were more than offset by a reduction in the duration of Group Life business in Switzerland.
* [[Definition:Foreign exchange|FX]] impact was mainly from JPY and HKD depreciation.
=== Life & Health – Strong momentum in both short-term and long-term business ===
{{chunk|doc=snjra2xp9r|c=
====== Life & Health gross revenues ======
* Gross revenues
* This growth was driven by Health and Protection lines.
* Health gross revenues increased by +7% LFL to EUR 19,000m.
* Protection gross revenues increased by +3% LFL to EUR 20,000m.
* Unit-Linked gross revenues decreased by -4% LFL to EUR 26,000m.
* General Account gross revenues decreased by -2% LFL to EUR 14,000m.
==== Underlying Earnings
{{chunk|doc=snjra2xp9r|c=
====== Underlying
* [[Definition:Underlying earnings per share|Underlying earnings per share]] increased by +7%.
{{chunk|doc=snjra2xp9r|c=44|p=20}}
====== Underlying Earnings ======
<div style="overflow-x:auto">
{| id="
|-
! style="text-align:left" |
! class="col-s" style="text-align:right" |
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | Short-term technical margin
| style="text-align:right" | 415
| style="text-align:right" | +60
| style="text-align:right" | 479
|-
| style="text-align:left" | Long-term result incl. CSM release
| style="text-align:right" | 2,680
| style="text-align:right" | +156
| style="text-align:right" | 2,804
|-
| style="text-align:left" | Financial result
| style="text-align:right" | 975
| style="text-align:right" | -11
| style="text-align:right" | 946
|-
| style="text-align:left" | Tax
| style="text-align:right" | -748
| style="text-align:right" | -27
| style="text-align:right" | -728
|-
| style="text-align:left" |
| style="text-align:right" | 3,323
| style="text-align:right" | +7%
| style="text-align:right" | 3,501
|}
</div>
{{chunk|doc=snjra2xp9r|c=
======
* Change is measured at constant [[Definition:Foreign exchange|FX]].
==== in billions ====
{{chunk|doc=snjra2xp9r|c=46|p=20}}
====== o/w Life & o/w Health by FY24 & FY25 ======
<div style="overflow-x:auto">
{| id="
|-
! style="text-align:left" |
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-m" style="text-align:right" |
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" | +4% vs. FY24
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" | +17% vs. FY24
|}
</div>
{{chunk|doc=snjra2xp9r|c=
======
* Short-term technical margin was strong, reflecting underwriting and claims initiatives that more than offset the impact of legislative change on the recoverability of value added tax in Mexico (EUR -0.1bn).
* Long-term results were higher due to an +8% increase in CSM release, reflecting growth in the reserve base, including from favorable equity market performance, and better margins.
=== Growth in net income reflecting higher earnings & the gain from the sale of AXA IM ===
{{chunk|doc=snjra2xp9r|c=48|p=21}}
====== Net income ======
* Net income: EUR 7.6bn (+7% reported)
* Net income per share: EUR 3.56 (+10% reported)
* [[Definition:Underlying earnings per share|Underlying earnings per share]]: EUR 3.20 (+12% reported)
{{chunk|doc=snjra2xp9r|c=49|p=21}}
====== Net income by segment ======
<div style="overflow-x:auto">
{| id="
|-
! style="text-align:left" |
! class="col-
! class="col-
! class="col-
|-
| style="text-align:left" | Property & Casualty
Line 883 ⟶ 774:
| style="text-align:right" | -
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" |
|-
| style="text-align:left" | Non-financial flows
Line 893 ⟶ 784:
| style="text-align:right" |
|-
| style="text-align:left" |
| style="text-align:right" | -
| style="text-align:right" | +2.2
Line 903 ⟶ 794:
| style="text-align:right" |
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" |
|}
</div>
{{chunk|doc=snjra2xp9r|c=
======
* [[Definition:Underlying earnings|Underlying earnings]] showed strong performance from insurance businesses.
* Holding cost was stable and is expected to remain at the current level in [[Definition:Year 2026|2026]].
* Net Income was higher, mainly reflecting higher underlying earnings and the gain from the sale of [[Definition:AXA Investment Managers|AXA IM]].
* Financial flows were lower, reflecting an unfavorable forex impact.
==== Underlying earnings per share ====
{{chunk|doc=snjra2xp9r|c=
====== Underlying earnings per share In Euro ======
<div style="overflow-x:auto">
{| id="
|-
! style="text-align:left" |
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" |
| style="text-align:right" | 3.59
| style="text-align:right" | 3.86
| style="text-align:right" | +8%
Line 945 ⟶ 829:
</div>
{{chunk|doc=snjra2xp9r|c=
====== Underlying
* [[Definition:Underlying earnings per share|Underlying
* Forex impact included -1% from temporary [[Definition:Earnings dilution|earnings dilution]] due to the timing of anti-dilutive [[Definition:Share buyback|share buyback]] related to the [[Definition:AXA Investment Managers|AXA IM]] sale
{{chunk|doc=snjra2xp9r|c=
====== Underlying earnings per share ======
{{fn note|1=1|2=Change at constant FX for underlying earnings and net income. Change on reported basis for underlying earnings per share.}}
===
{{chunk|doc=snjra2xp9r|c=
====== Shareholders' Equity ======
* Shareholders' Equity is presented in EUR billion.
====
{{chunk|doc=snjra2xp9r|c=
====== Shareholders' equity by period ======
<div style="overflow-x:auto">
{| id="
|-
! style="text-align:left" | in Euro billion
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | HY25
Line 988 ⟶ 870:
| style="text-align:right" | -6.8
|-
| style="text-align:left" | Total Shareholders'
| style="text-align:right" | 49.9
| style="text-align:right" | 45.5
Line 1,010 ⟶ 892:
</div>
{{chunk|doc=snjra2xp9r|c=
======
<div style="overflow-x:auto">
{| id="
|-
! style="text-align:left" | In Euro billion
! class="col-s" style="text-align:right" | FY24 to FY25
! class="col-s" style="text-align:right" | HY25 to FY25
Line 1,061 ⟶ 943:
|}
</div>
{{fn note|1=1|2=Shareholders’ equity Group share. Full Year 2025 Earnings}}
=== Higher organic cash remittance and robust cash position at Holding ===
{{chunk|doc=snjra2xp9r|c=
======
*
* Cash at Holding: EUR 4.2bn
{{chunk|doc=snjra2xp9r|c=58|p=23}}
====== Net Cash Remittance by Proceeds related to in-force treaties ======
<div style="overflow-x:auto">
{| id="
|-
! style="text-align:left" |
! class="col-s" style="text-align:right" | FY24
! class="col-
|-
| style="text-align:left" | Remittance
| style="text-align:right" | 7.1
| style="text-align:right" | 7.5
|-
| style="text-align:left" | Proceeds related to in-force treaties{{fn ref|2}}
| style="text-align:right" | 0.6
| style="text-align:right" |
|-
| style="text-align:left" | Total
| style="text-align:right" | 7.7
| style="text-align:right" |
|-
| style="text-align:left" | Remittance ratio{{fn ref|1}}
| style="text-align:right" | 82%
| style="text-align:right" | 82%
Line 1,101 ⟶ 981:
</div>
{{chunk|doc=snjra2xp9r|c=
======
<div style="overflow-x:auto">
{| id="
|-
|-
| style="text-align:left" | Net cash remittance from subsidiaries
Line 1,136 ⟶ 1,016:
</div>
{{fn note|1=1|2=1. Based on ordinary cash remittance of Euro 7.1 billion in FY24 and Euro 7.5 billion in FY25.}}
{{fn note|1=2|2=2. €0.6bn proceeds related to L&S reinsurance in-force treaties at AXA France and AXA Life Europe.}}
=== Solvency II at 224% ===
{{chunk|doc=snjra2xp9r|c=
====== Foreseeable dividends and share buyback provision ======
* Foreseeable [[Definition:Dividend|dividends]]: -EUR
* Provision for annual [[Definition:Share buyback|share buyback]] for [[Definition:Year 2026|2026]]: -EUR
{{chunk|doc=snjra2xp9r|c=
====== In Euro billion ======
<div style="overflow-x:auto">
{| id="
|-
! style="text-align:left" |
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | Regulatory
! class="col-s" style="text-align:right" | Normalized capital generation
! class="col-s" style="text-align:right" | Operating variance
! class="col-s" style="text-align:right" | Economic variance & FX
! class="col-s" style="text-align:
! class="col-s" style="text-align:right" | Management actions, debt & other
! class="col-s" style="text-align:right" | FY25
Line 1,169 ⟶ 1,049:
| style="text-align:right" | -0.4
| style="text-align:right" | -2.1
| style="text-align:
| style="text-align:right" | -0.1
| style="text-align:right" | 56.4
|-
Line 1,179 ⟶ 1,059:
| style="text-align:right" | -1pt
| style="text-align:right" | +4pts
| style="text-align:
| style="text-align:right" | +2pts
| style="text-align:right" | 224%
Line 1,189 ⟶ 1,069:
| style="text-align:right" | 0.0
| style="text-align:right" | -1.2
| style="text-align:
| style="text-align:right" | -0.2
| style="text-align:right" | 25.2
Line 1,197 ⟶ 1,077:
==== Key sensitivities ====
{{chunk|doc=snjra2xp9r|c=
======
<div style="overflow-x:auto">
{| id="
|-
|-
| style="text-align:left" | Interest rate +50bps
Line 1,248 ⟶ 1,123:
=== Solvency II – impact of the end of grandfathering period and Solvency II revision ===
{{chunk|doc=snjra2xp9r|c=
====== Solvency II
* Solvency II
* Impact of the end of the grandfathering period on January 1, [[Definition:Year 2026|2026]]: -10pts,
* EUR 2.4bn of grandfathered debt will no longer be eligible as capital from January 1, 2026
* Impact of Solvency II revision,
* No change expected in organic capital generation
* Additional capital flexibility
{{chunk|doc=snjra2xp9r|c=64|p=25}}
====== Solvency II – impact of the end of grandfathering period and Solvency II revision ======
{{fn note|1=1|2=Estimated based on the Solvency Capital Requirement (SCR) and the amount of capital (EOF) under Solvency II as of January 1, 2026, as if the Solvency II revision had come into force on the same date.}}
== Conclusion ==
{{chunk|doc=snjra2xp9r|c=
====== Group CEO ======
Line 1,267 ⟶ 1,147:
=== Conclusion ===
{{chunk|doc=snjra2xp9r|c=
====== Business performance and outlook ======
*
* All businesses are in excellent shape, delivering strong growth and profitability.
* The diversified franchise is well-positioned to capture future growth opportunities.
* Laying foundations for the next plan and confident in delivering sustainable earnings growth.
=== Q&A ===
{{chunk|doc=snjra2xp9r|c=
======
*
=== AXA Investor Relations – Keep in touch ===
Line 1,284 ⟶ 1,166:
==== Meet our management ====
{{chunk|doc=snjra2xp9r|c=
======
* Upcoming events include: March Roadshows Europe and US; May 5 1Q25 Activity Indicators Paris; June 2 BNP Paribas Exane CEO Conference Paris; June 2-4 Goldman Sachs European Financials Conference Zurich; July 31 HY26 [[Definition:Earnings release|Earnings Release]] Paris; September 21 AXA Investor Day London.
* Investor Relations contact: +33 1 40 75 48 42, investor.relations@axa.com.
* Follow AXA at www.axa.com.
== Appendices ==
Line 1,313 ⟶ 1,177:
=== Contents ===
{{chunk|doc=snjra2xp9r|c=
====== Additional disclosures ======
* Additional disclosures include: Debt and Invested Assets; Additional P&C disclosures;
=== Gross financial debt and maturity breakdown as of December 31st, 2025 ===
==== Gross financial debt ====
{{chunk|doc=snjra2xp9r|c=70|p=32}}
====== Gross financial debt by tier and senior debt ======
<div style="overflow-x:auto">
{| id="
|-
! style="text-align:left" | in Euro billion
! class="col-
! class="col-
! class="col-
|-
| style="text-align:left" | Debt gearing
| style="text-align:right" | 20.6%
| style="text-align:right" | 22.3%
| style="text-align:right" | -
|-
| style="text-align:left" | Tier 1
Line 1,358 ⟶ 1,215:
| style="text-align:right" | 3.5
| style="text-align:right" | 3.5
| style="text-align:right" | 5.8 {{fn ref|*|2=o/w €0.4bn redeemed in Jan 2026}}
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" |
|}
</div>
{{fn note|1=*|2=o/w €0.4bn redeemed in Jan 2026}}
==== Contractual maturity breakdown ====
{{chunk|doc=snjra2xp9r|c=
======
<div style="overflow-x:auto">
{| id="
|-
! style="text-align:left" | Segment
! class="col-s" style="text-align:right" | 2025
! class="col-s" style="text-align:right" | 2026
Line 1,392 ⟶ 1,246:
|-
| style="text-align:left" | Senior debt
| style="text-align:right" | -
| style="text-align:right" | -
| style="text-align:right" | -
| style="text-align:right" | 0.5
| style="text-align:right" | -
| style="text-align:right" | 0.9
| style="text-align:right" | 1.5
| style="text-align:right" |
| style="text-align:right" | -
|-
| style="text-align:left" | Tier 2
| style="text-align:right" | -
| style="text-align:right" | -
| style="text-align:right" | -
| style="text-align:right" |
| style="text-align:right" | -
| style="text-align:right" | 0.7
| style="text-align:right" | -
| style="text-align:right" | 10.8
| style="text-align:right" | 0.7
|-
| style="text-align:left" | Tier 1
| style="text-align:right" | -
| style="text-align:right" | -
| style="text-align:right" | -
| style="text-align:right" | -
| style="text-align:right" | -
| style="text-align:right" | -
| style="text-align:right" | -
| style="text-align:right" | -
| style="text-align:right" | 4.6
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" |
Line 1,421 ⟶ 1,287:
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" |
|-
| style="text-align:left" | Tier 1
Line 1,471 ⟶ 1,315:
==== Economic maturity breakdown ====
{{chunk|doc=snjra2xp9r|c=
====== Economic maturity breakdown (
<div style="overflow-x:auto">
{| id="
|-
! style="text-align:left" | Segment
! class="col-s" style="text-align:right" | 2025
! class="col-s" style="text-align:right" | 2026
Line 1,489 ⟶ 1,333:
|-
| style="text-align:left" | Senior debt
| style="text-align:right" | -
| style="text-align:right" | 0.1
| style="text-align:right" | -
| style="text-align:right" | 0.5
| style="text-align:right" | -
| style="text-align:right" | 0.9
| style="text-align:right" | 1.5
| style="text-align:right" |
| style="text-align:right" | -
|-
| style="text-align:left" | Tier 2
| style="text-align:right" | -
| style="text-align:right" |
| style="text-align:right" | 2.4
| style="text-align:right" | 0.
| style="text-align:right" | 2.0
| style="text-align:right" | 0.
| style="text-align:right" | 6.4
| style="text-align:right" | -
| style="text-align:right" | 0.7
|-
| style="text-align:left" | Tier 1
| style="text-align:right" |
| style="text-align:right" | -
| style="text-align:right" | -
| style="text-align:right" | -
| style="text-align:right" | -
| style="text-align:right" | -
| style="text-align:right" | 0.4
| style="text-align:right" | 0.5
| style="text-align:right" | 4.0
|-
| style="text-align:left" | o/w Grandfathered debt
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" |
|-
| style="text-align:left" | Tier 1
Line 1,566 ⟶ 1,400:
</div>
{{fn note|1=1|2=Nominal debt.}}
{{fn note|1=2|2=In January 2026, AXA has called (i) the remaining T2 GF £139m due 2054 callable 2034 5.625% issued January 2014 and (ii) the T1 GF €250m perpetual callable 2010 floating issued January 2005.}}
{{fn note|1=3|2=Economic maturity is taking into account the first date of step up calls on institutionally placed subordinated debt. For Solvency 2 RT1 debt, that has no step-up, the undated nature of the instrument is retained for the purpose of this diagram. This should not be construed, nor relied upon, as an indication that the instrument will not be called for redemption when callable. Such decision will depend on several factors, including our capital and liquidity position and the refinancing economics at the prevailing time.}}
=== General Account Invested Assets ===
==== FY25 Total General Account invested assets ====
{{chunk|doc=snjra2xp9r|c=73|p=33}}
* Duration gap: -0.4 year
* Invested assets include: Fixed income, Real estate, Infrastructure equity, Listed equities, Private equity and hedge funds, Cash, Policy loans
{{chunk|doc=snjra2xp9r|c=74|p=33}}
====== Invested assets (100%) In Euro billion ======
<div style="overflow-x:auto">
{| id="
|-
! style="text-align:left" |
Line 1,628 ⟶ 1,437:
| style="text-align:right" | 27%
|-
| style="text-align:left" | o/w Other fixed income
| style="text-align:right" | 56
| style="text-align:right" | 13%
Line 1,640 ⟶ 1,449:
| style="text-align:right" | 2%
|-
| style="text-align:left" | Listed equities
| style="text-align:right" | 10
| style="text-align:right" | 2%
|-
| style="text-align:left" | Private equity and hedge funds
| style="text-align:right" | 23
| style="text-align:right" | 5%
Line 1,656 ⟶ 1,465:
| style="text-align:right" | 0%
|-
| style="text-align:left" | Total Insurance Invested Assets
| style="text-align:right" | 450
| style="text-align:right" | 100%
Line 1,662 ⟶ 1,471:
</div>
{{fn note|1=1|2=Other fixed income includes Asset Backed Securities (Euro 25 billion), Residential Loans (Euro 16 billion), Commercial & Agricultural Loans (Euro 7 billion) and Agency Pools (Euro 8 billion).}}
{{fn note|1=2|2=Includes hedges. Listed equities excluding hedges at Euro 14 billion.}}
{{fn note|1=3|2=Includes Private Equity (Euro 17 billion), Hedge Funds (Euro 5 billion) and Non-listed Equities (Euro 1 billion).}}
Line 1,669 ⟶ 1,478:
=== Structured and Private Credit assets ===
{{chunk|doc=snjra2xp9r|c=
======
<div style="overflow-x:auto">
{| id="
|-
! style="text-align:left" |
! class="col-
! class="col-
! style="text-align:left" | Comments
|-
Line 1,710 ⟶ 1,519:
| style="text-align:left" |
|-
| style="text-align:left" | <
| style="text-align:right" | <
| style="text-align:right" | <
| style="text-align:left" | o/w 54% participating
|}
Line 1,723 ⟶ 1,532:
==== FY25 Fixed Income Reinvestment ====
{{chunk|doc=snjra2xp9r|c=
====== FY25
<div style="overflow-x:auto">
{| id="t30" class="wikitable fintable"
|-
| style="text-align:left" | Government bonds & related (32%) – Average rating: AA
| style="text-align:right" | 32%
|-
| style="text-align:left" | Investment grade credit (40%)- Average rating: A
| style="text-align:right" | 40%
|-
| style="text-align:left" | ABS/CLO/IG fund financing (21%)
| style="text-align:right" | 21%
|-
| style="text-align:left" | Below investment grade credit (7%)
| style="text-align:right" | 7%
|}
</div>
==== FY25 Fixed Income Reinvestment Yield ====
{{chunk|doc=snjra2xp9r|c=
======
<div style="overflow-x:auto">
{| id="
|-
! style="text-align:left" | Category
! class="col-s" style="text-align:right" | Yield
|-
| style="text-align:left" | Public fixed income{{fn ref|1}}
| style="text-align:right" | 3.5%
|-
|-
| style="text-align:left" |
| style="text-align:right" | 3.9%
|}
</div>
{{chunk|doc=snjra2xp9r|c=
====== Fixed income
* EUR 57bn fixed income invested at 3.9%
Line 1,758 ⟶ 1,582:
* Gradual shift from alternative total return assets to Private & Structured credit
{{chunk|doc=snjra2xp9r|c=
====== FY25 Fixed Income Reinvestment Yield ======
{{fn note|1=1|2=Government and Corporate bonds and related.}}
{{fn note|1=2|2=Private & Structured credit (CLOs, ABS, Infra & CRE debt, Fund financing and Private hybrid).}}
{{chunk|doc=snjra2xp9r|c=80|p=35}}
====== FY25 earnings ======
* [[Definition:Full year 2025|Full Year 2025]] Earnings
=== Contents ===
{{chunk|doc=snjra2xp9r|c=
======
* Additional disclosures include: Debt and Invested Assets
=== AXA XL Insurance – Large Commercial & Specialty business ===
Line 1,777 ⟶ 1,604:
==== Well diversified across lines of business and geographies ====
{{chunk|doc=snjra2xp9r|c=
======
<div style="overflow-x:auto">
{| id="t32" class="wikitable fintable"
|-
| style="text-align:left" | Casualty
| style="text-align:right" | 35%
|-
| style="text-align:left" | Property
| style="text-align:right" | 29%
|-
| style="text-align:left" | Specialty
| style="text-align:right" | 19%
|-
| style="text-align:left" | Professional lines{{fn ref|1}}
| style="text-align:right" | 17%
|}
</div>
{{chunk|doc=snjra2xp9r|c=
======
<div style="overflow-x:auto">
{| id="t33" class="wikitable fintable"
|-
| style="text-align:left" | Americas
| style="text-align:right" | 46%
|-
| style="text-align:left" | Europe & APAC
| style="text-align:right" | 35%
|-
| style="text-align:left" | UK & Lloyds
| style="text-align:right" | 19%
|}
</div>
==== Leading market positions across lines ====
{{chunk|doc=snjra2xp9r|c=
======
* Top 3 globally in Multinational Programs, Marine, and Fine Art & Specie.
* Profitability vs.
{{chunk|doc=snjra2xp9r|c=85|p=37}}
====== Leading market positions across lines ======
{{fn note|1=1|2=Including Cyber;}}
{{fn note|1=2|2=Source: McKinsey;}}
{{fn note|1=3|2=Source: Aon, Guy Carpenter, and Global Market Insights;}}
{{fn note|1=4|2=Source: Industry Research Biz (January 2026).}}
=== P&C – Focus on Reserves ===
{{chunk|doc=snjra2xp9r|c=86|p=38}}
====== Claims reserves ratio (Net undiscounted claims reserves/Net earned premiums) ======
<div style="overflow-x:auto">
{| id="
|-
! colspan="5" style="text-align:
!
|-
! style="text-align:left" | FY18
! class="col-s" style="text-align:right" | FY19
! class="col-s" style="text-align:right" | FY20
! class="col-s" style="text-align:right" | FY21
! class="col-s" style="text-align:right" | FY22
! class="col-s" style="text-align:right" | FY22
! class="col-s" style="text-align:right" | FY23
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" |
| style="text-align:right" | 185%
| style="text-align:right" | 193%
Line 1,863 ⟶ 1,690:
</div>
{{chunk|doc=snjra2xp9r|c=87|p=38}}
====== Technical reserves ratio (Net undiscounted technical reserves/Net earned premiums) ======
<div style="overflow-x:auto">
{| id="
|-
! colspan="5" style="text-align:
!
|-
! style="text-align:left" | FY18
! class="col-s" style="text-align:right" | FY19
! class="col-s" style="text-align:right" | FY20
! class="col-s" style="text-align:right" | FY21
! class="col-s" style="text-align:right" | FY22
! class="col-s" style="text-align:right" | FY22
! class="col-s" style="text-align:right" | FY23
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" |
| style="text-align:right" | 227%
| style="text-align:right" | 233%
Line 1,904 ⟶ 1,725:
=== P&C – 2026 Simplified Group Nat Cat Reinsurance Program ===
{{chunk|doc=snjra2xp9r|c=
======
* The [[Definition:Year 2026|2026]] Simplified Group Nat Cat Reinsurance Program is denominated in Euro.
==== Insurance segment (occurrence protection) ====
{{chunk|doc=snjra2xp9r|c=
====== Capacity & Retention by
<div style="overflow-x:auto">
{| id="
|-
! style="text-align:left" | Peril
! class="col-s" style="text-align:right" |
! class="col-s" style="text-align:right" |
|-
| style="text-align:left" |
| style="text-align:right" | 4.0bn
| style="text-align:right" | 600m
|-
| style="text-align:left" | Europe Flood
| style="text-align:right" | 2.1bn
| style="text-align:right" | 450m
|-
| style="text-align:left" | Europe Earthquake
| style="text-align:right" | 2.1bn
| style="text-align:right" | 400m
|-
| style="text-align:left" | NA Hurricane
| style="text-align:right" | 1.2bn
| style="text-align:right" | 600m{{fn ref|2}}
|-
| style="text-align:left" | NA Earthquake
| style="text-align:right" | 1.2bn
| style="text-align:right" | 600m{{fn ref|2}}
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" | 400m
|}
</div>
==== Reinsurance segment (illustrative) ====
{{chunk|doc=snjra2xp9r|c=90|p=39}}
====== Alternative Capital & Cat Bonds ======
* Alternative Capital & Cat Bonds
* Stable retention levels are expected to be maintained in [[Definition:Year 2026|2026]], consistent with 2025 levels.
{{chunk|doc=snjra2xp9r|c=
====== Reinsurance segment (illustrative) ======
{{fn note|1=1|2=Excludes local reinsurance covers;}}
Line 1,958 ⟶ 1,785:
=== P&C – AXA Group earnings deviation with different levels of Nat Cat cost in 2026 ===
{{chunk|doc=snjra2xp9r|c=
====== P&C Nat Cat cost deviation ======
*
==== Group underlying earnings deviation to average Nat Cat charges in 2026 net of reinsurance, post-tax ====
{{chunk|doc=snjra2xp9r|c=
======
*
* Net of reinsurance, pre-tax
* More severe years: Negative deviation in approximately 40% of cases
* Less severe years: Positive deviation in approximately 60% of cases
{{chunk|doc=snjra2xp9r|c=
====== Deviation by
<div style="overflow-x:auto">
{| id="
|-
! style="text-align:left" |
! style="text-align:right" | Percentile
! style="text-align:right" | Deviation
|-
| style="text-align:left" | 1/20y
| style="text-align:right" |
| style="text-align:right" | €-1.2bn
|-
| style="text-align:left" | 1/10y
| style="text-align:right" |
| style="text-align:right" | €-0.8bn
|-
| style="text-align:left" | 1/5y
| style="text-align:right" |
| style="text-align:right" | €-0.4bn
|-
| style="text-align:left" | Median
| style="text-align:right" | (50th)
| style="text-align:right" | €+0.1bn
|-
| style="text-align:left" | 1/5y
| style="text-align:right" |
| style="text-align:right" | €+0.5bn
|-
| style="text-align:left" | 1/10y
| style="text-align:right" |
| style="text-align:right" | €+0.7bn
|-
| style="text-align:left" | 1/20y
| style="text-align:right" |
| style="text-align:right" | €+0.8bn
|}
</div>
==== Average Expected Nat Cat charges net of reinsurance, pre-tax ====
{{chunk|doc=snjra2xp9r|c=95|p=40}}
====== Charges & Estimated impact on GEP by Year ======
<div style="overflow-x:auto">
{| id="
|-
! style="text-align:left" | Year
! style="text-align:right" |
! style="text-align:right" |
|-
| style="text-align:left" |
| style="text-align:right" | 2.6
| style="text-align:right" | ca. 4.5%
|-
| style="text-align:left" | 2026
| style="text-align:right" | 2.7
| style="text-align:right" | ca. 4.5%
|}
</div>
{{fn note|1=1|2=Natural catastrophe cost defined as Aggregate Exceedance Probability (AEP) of all natural perils worldwide, net of tax and reinsurance. Deviation is compared to a normalized level, which are costs associated with natural catastrophes expected in an average year (ca. 4.5 points of estimated FY25 GEP, undiscounted and net of reinsurance).
=== Contents ===
{{chunk|doc=snjra2xp9r|c=
======
*
* Additional P&C disclosures are on
* Additional IFRS17 disclosures are on
* Sustainability disclosures are on page 44.
=== P&C – Margin Analysis ===
Line 2,053 ⟶ 1,878:
==== Technical Result ====
{{chunk|doc=snjra2xp9r|c=
====== Pre-tax technical result ======
*
{{chunk|doc=snjra2xp9r|c=
====== Current Accident Year Undiscounted Technical Margin by
<div style="overflow-x:auto">
{| id="
|-
! style="text-align:left" |
Line 2,068 ⟶ 1,893:
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" |
| style="text-align:right" | 2,778
| style="text-align:right" | +707
|-
| style="text-align:left" | Gross Earned Premiums
Line 2,094 ⟶ 1,911:
</div>
{{chunk|doc=snjra2xp9r|c=
======
<div style="overflow-x:auto">
{| id="
|-
! style="text-align:left" |
Line 2,104 ⟶ 1,921:
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" |
| style="text-align:right" | 2,009
| style="text-align:right" | +115
Line 2,126 ⟶ 1,943:
</div>
{{chunk|doc=snjra2xp9r|c=
====== Prior Years' Reserve Development (PYD) & PYD ratio by FY25 & Change ======
<div style="overflow-x:auto">
{| id="
|-
! style="text-align:left" |
Line 2,136 ⟶ 1,953:
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" |
| style="text-align:right" | 622
| style="text-align:right" | -341
Line 2,146 ⟶ 1,963:
</div>
{{chunk|doc=snjra2xp9r|c=
======
* [[Definition:Full year 2025|FY25]] sensitivity to Current Accident Year discount rate changes:
** +25bps: EUR +0.2bn
** -25bps: EUR -0.2bn
==== Financial Result ====
{{chunk|doc=snjra2xp9r|c=
====== Pre-tax results ======
* All figures are in EUR million (pre-tax).
{{chunk|doc=snjra2xp9r|c=
====== Investment
<div style="overflow-x:auto">
{| id="
|-
! style="text-align:left" |
Line 2,177 ⟶ 1,987:
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" |
| style="text-align:right" | 3,988
| style="text-align:right" | +435
Line 2,195 ⟶ 2,005:
</div>
{{chunk|doc=snjra2xp9r|c=
====== Insurance
<div style="overflow-x:auto">
{| id="
|-
! style="text-align:left" |
Line 2,205 ⟶ 2,015:
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" |
| style="text-align:right" | -1,358
| style="text-align:right" | -235
Line 2,219 ⟶ 2,029:
</div>
{{chunk|doc=snjra2xp9r|c=
======
* 2026e Insurance Finance Expenses (pre-tax) are projected at approximately EUR -1.4bn.
* The sensitivity of 2026e Insurance Finance Expenses to changes in 2025 current AY Discount is:
** A +25bps change results in approximately EUR -50m.
** A -25bps change results in approximately EUR +50m.
{{chunk|doc=snjra2xp9r|c=
====== Underlying
<div style="overflow-x:auto">
{| id="
|-
! style="text-align:left" |
Line 2,243 ⟶ 2,047:
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" |
| style="text-align:right" | 8,040
| style="text-align:right" | +681
Line 2,255 ⟶ 2,059:
| style="text-align:right" | -10
|-
| style="text-align:left" |
| style="text-align:right" | 5,872
| style="text-align:right" | +501
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" | +9%
Line 2,265 ⟶ 2,069:
</div>
{{chunk|doc=snjra2xp9r|c=107|p=42}}
====== Financial result definitions ======
* Changes versus [[Definition:Full year 2024|FY24]] are at constant [[Definition:Foreign exchange|FX]].
* Reinvestment yield on fixed income assets is defined as (1).
* Parallel shift of the full-year average yield curve (average of monthly opening discount rates of 2025) used for discounting [[Definition:Full year 2025|FY25]] current accident year net reserve is defined as (2).
=== L&H – Margin Analysis ===
{{chunk|doc=snjra2xp9r|c=
====== Scope impact ======
Line 2,277 ⟶ 2,085:
==== Technical Result ====
{{chunk|doc=snjra2xp9r|c=
====== Pre-tax technical result ======
*
{{chunk|doc=snjra2xp9r|c=
======
<div style="overflow-x:auto">
{| id="
|-
! style="text-align:left" |
Line 2,292 ⟶ 2,100:
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" |
| style="text-align:right" | 479
| style="text-align:right" | +60
Line 2,303 ⟶ 2,111:
| style="text-align:right" | 97.2%
| style="text-align:right" | -0.1pts
|-
|-
| style="text-align:left" |
| style="text-align:right" | 2,804
| style="text-align:right" | +156
Line 2,332 ⟶ 2,127:
| style="text-align:right" | -150
| style="text-align:right" | -58
|}
</div>
Line 2,372 ⟶ 2,132:
==== Financial Result ====
{{chunk|doc=snjra2xp9r|c=
====== Pre-tax
* All figures are in EUR million, pre-tax.
{{chunk|doc=snjra2xp9r|c=
====== Investment income
<div style="overflow-x:auto">
{| id="
|-
! style="text-align:left" |
Line 2,394 ⟶ 2,147:
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" |
| style="text-align:right" | 2,484
| style="text-align:right" | -1
Line 2,409 ⟶ 2,162:
| style="text-align:right" | 3.8%
| style="text-align:right" |
|-
| style="text-align:left" |
| style="text-align:right" | -1,538
| style="text-align:right" | -9
Line 2,436 ⟶ 2,177:
</div>
==== Life & Health FY25 CSM Key Sensitivities ====
{{chunk|doc=snjra2xp9r|c=113|p=43}}
====== CSM sensitivity to interest rates ======
* CSM sensitivity to interest rates is EUR -0.2bn for a +50bps change and EUR +0.2bn for a -50bps change.
{{chunk|doc=snjra2xp9r|c=114|p=43}}
====== Life & Health FY25 CSM Key Sensitivities ======
<div style="overflow-x:auto">
{| id="
|-
| style="text-align:left" | <b>Baseline</b>
| style="text-align:right" | <b>33.3</b>
|-
| style="text-align:left" | Interest rates +50bps
| style="text-align:right" | -0.8
|-
| style="text-align:left" | Interest rates -50bps
| style="text-align:right" | 0.6
|-
| style="text-align:left" | Sovereign spreads +50bps
| style="text-align:right" | -1.9
|-
| style="text-align:left" | Sovereign spreads -50bps
| style="text-align:right" | 1.9
|-
| style="text-align:left" | Corporate spread +50bps
| style="text-align:right" | -0.8
|-
| style="text-align:left" | Corporate spread -50bps
| style="text-align:right" | 0.7
|-
| style="text-align:left" | Equities +25%
| style="text-align:right" | 1.8
|-
| style="text-align:left" | Equities -25%
| style="text-align:right" | -2.2
|}
</div>
{{chunk|doc=snjra2xp9r|c=115|p=43}}
====== Life & Health FY25 CSM Key Sensitivities ======
<div style="overflow-x:auto">
{| id="t48" class="wikitable fintable"
|-
! style="text-align:left" |
Line 2,446 ⟶ 2,229:
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" |
| style="text-align:right" | 4,229
| style="text-align:right" | +205
Line 2,458 ⟶ 2,241:
| style="text-align:right" | -51
|-
| style="text-align:left" |
| style="text-align:right" | 3,501
| style="text-align:right" | +219
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" | +7%
Line 2,470 ⟶ 2,253:
{{fn note|1=1|2=Reinvestment yield on fixed income assets.}}
===
{{chunk|doc=snjra2xp9r|c=
====== Additional disclosures ======
* Additional disclosures include Debt and Invested Assets on p.31, Additional P&C disclosures on p.36, and Additional IFRS17 disclosures on p.41.
=== Expanding
==== As a GLOBAL INVESTOR ====
{{chunk|doc=snjra2xp9r|c=117|p=45}}
====== Climate transition and community resilience financing per year ======
<div style="overflow-x:auto">
{| id="
|-
! style="text-align:left" | Target
! style="text-align:right" | 2025 Result
|-
| style="text-align:right" | €6.4bn
|-
| style="text-align:left" | >€500m{{fn ref|2}}<br/> in community resilience financing per year
| style="text-align:right" | €1.4bn
|}
</div>
==== As a GLOBAL INSURER ====
{{chunk|doc=snjra2xp9r|c=118|p=45}}
====== Target by 2025 Result ======
<div style="overflow-x:auto">
{| id="t50" class="wikitable"
|-
! style="text-align:left" | Target
! style="text-align:right" | 2025 Result
|-
| style="text-align:left" |
| style="text-align:right" | €4.6bn
|-
| style="text-align:left" | >
| style="text-align:right" |
|-
| style="text-align:left" | >20m{{fn ref|5|2=Low-income to mass market segments in emerging markets and modest income segments in mature markets.}}<br/> inclusive insurance customers by 2026
| style="text-align:right" | 20.6m
|}
</div>
==== As a COMPANY ====
{{chunk|doc=snjra2xp9r|c=119|p=45}}
====== Target by 2025 Result ======
<div style="overflow-x:auto">
{| id="t51" class="wikitable fintable"
|-
! style="text-align:left" | Target
! class="col-m" style="text-align:right" | 2025 Result
|-
| style="text-align:left" | >80,000{{fn ref|6|2=Number of employees who have been trained on climate change adaptation, completing a training under the AXA Sustainability Academy. Timeframe: cumulative 2024-2026.}}<br/> AXA Group employees trained on climate adaptation by 2026
| style="text-align:right" | 46,420
|-
| style="text-align:left" | Contribute to Net-Zero<br/> -50%{{fn ref|7|2=Variation of AXA Group absolute carbon emissions (scope: energy Scopes 1 and 2, car fleet and business travel). Timeframe: 2019-2030.}} by 2030<br/> in absolute carbon emissions and offset of residual emissions{{fn ref|8|2=Carbon credits from projects that focus on capturing and storing carbon emissions from the atmosphere using nature-based or technical solutions (e.g. restorative agriculture, forest restoration or carbon capture and storage).}}
| style="text-align:right" | -64%<br/>Reduction against 2019
|-
| style="text-align:left" | 50% Percentage of AXA Group employees engaged in volunteering activities by 2026
| style="text-align:right" | 56%
Line 2,520 ⟶ 2,325:
</div>
{{fn note|1=1|2=
{{fn note|1=2|2=Scope: corporate and sovereign debt, real estate and private assets. Timeframe: per annum through 2030.}}
{{fn note|1=3|2=Scope: AXA France, AXA Germany, AXA Switzerland, AXA UK & Ireland, AXA Belgium, AXA Hong Kong, AXA Mexico, and AXA XL; Unit: Gross Written Premiums (GWP); Timeframe: cumulative 2024-2026.}}
Line 2,531 ⟶ 2,336:
=== Sustainability Performance & Ratings ===
{{chunk|doc=snjra2xp9r|c=
====== Sustainability
*
* MSCI ESG Ratings: AAA score
* CDP Climate Change: B score
*
*
{{chunk|doc=snjra2xp9r|c=
====== Sustainability Performance & Ratings ======
Line 2,547 ⟶ 2,352:
=== Scope ===
{{chunk|doc=snjra2xp9r|c=
====== Scope
* France: includes insurance activities, banking activities, and holding.
Line 2,554 ⟶ 2,359:
* AXA XL: includes insurance and reinsurance activities and holding.
* Asia, Africa & EME-LATAM:
** Asia: Japan (insurance activities and holding), Hong Kong (insurance activities), Thailand P&C, China P&C, South Korea, and Asia Holdings
** Asia (equity method): China L&S, Thailand L&S, the Philippines L&S and P&C, Indonesia L&S, and India (Life activities disposed on March 11, 2024 and holding) businesses,
** Africa: Morocco (insurance activities and holding), Nigeria (insurance activities and holding), Egypt (insurance activities and holding)
** EME-LATAM: Mexico (insurance activities), Colombia (insurance activities), Brazil (insurance activities and holding), and Türkiye (insurance activities and holding)
** EME-LATAM (equity method): Russia (Reso) (insurance activities),
** Other: AXA Mediterranean Holdings
* Transversal & Other: includes AXA Assistance, AXA Liabilities Managers, AXA, and other Central Holdings.
* [[Definition:AXA Investment Managers|AXA Investment Managers]] (until July 1, 2025): includes AXA Investment Managers, Select (previously Architas), and Capza
* All comparative figures going back to 2023 are under IFRS17/9 accounting standards, effective January 1, 2023, unless otherwise specified.
* Figures for financial periods prior to 2023 have not been restated under IFRS17/9 and are presented under IFRS4.
Line 2,572 ⟶ 2,372:
=== Glossary ===
{{chunk|doc=snjra2xp9r|c=
====== Glossary of
* Capital-light G/A products: encompass all products with no guarantees, with guarantees at maturity only, or with guarantees equal to or lower than 0%.
Line 2,579 ⟶ 2,379:
* CSM release: a portion of CSM stock net of reinsurance at the end of the defined period flowing through profit and loss, representing the estimated profit earned by the insurer for providing insurance services during the reporting period.
* Economic variance: corresponds to the variance of the year-end CSM arising from changes in market conditions, net of the underlying return on in-force.
* Financial result: consists of investment income on assets backing BBA and PAA contracts as well as assets backing
* [[Definition:Gross written premiums|Gross Written Premiums]] and [[Definition:Other revenue|Other Revenues]] ([[Definition:Gross written premiums & other revenues|GWP & Other Revenues]]): represent the insurance premiums collected during the period (including risk premiums, premiums from pure investment contracts with no discretionary participating features, fees and revenues, net of commissions paid on assumed reinsurance business).
* Other Revenues: represent premiums and fees collected on activities other than insurance (i.e.
* New Business Value (NBV): the value of newly issued contracts during the current year, consisting of the sum of (i) the new business contractual service margin, (ii) the present value of the future profits of short-term newly issued contracts during the period (carried by Life entities, considering expected renewals), (iii) the present value of the future profits of pure investment contracts accounted for under IFRS 9, net of (iv) the cost of reinsurance, (v) taxes, and (vi) minority interests.
* New Business Contractual Service Margin (NB CSM): a component of the carrying amount of the asset or liability for newly issued insurance contracts during the period, representing the unearned profit to be recognized as insurance contract services are provided.
Line 2,590 ⟶ 2,390:
* Underlying return on in-force: represents the release of Time Value of Options & Guarantees (TVOG) plus the unwind of CSM at the reference rate plus the underlying financial over-performance.
=== Thank you
{{chunk|doc=snjra2xp9r|c=124|p=49}}
====== Full Year 2025 Earnings ======
* [[Definition:Full year 2025|Full Year 2025]] Earnings
| |||